Ovid Therapeutics Inc (OVID) — Cash Flow Quality Index
Ovid Therapeutics Inc (OVID) has a Cash Flow Quality Index of -1.08x as of December 2025. Operating cash flow of $-10.41 Million is below net income of $9.66 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Ovid Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ovid Therapeutics Inc Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Ovid Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see OVID cash flow metrics.
Annual Cash Flow Quality Index for Ovid Therapeutics Inc (2021–2021)
Year-by-year earnings quality comparison for Ovid Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 0.97x | $118.61 Million | $122.83 Million | — |